Local view for "http://purl.org/linkedpolitics/eu/plenary/2004-04-20-Speech-2-487"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20040420.22.2-487"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
".
Mr President, the basic regulation establishing the European Monitoring Centre for Drugs and Drug addiction has now been in place for ten years. It has been amended only on an ad hoc basis. The aim of the proposal was to reform the basic regulation on the Centre in order to take into account the evolution in the patterns of drug use, the way in which the Centre currently operates, the effects of enlargement and the horizontal measures that the Commission would like to see applied to agencies in general. The legal basis of the Centre remains unchanged: it is Article 308.
The main changes from the previous regulation are as follows. Firstly, there is the strengthened role of the Centre. The Commission proposes that the Centre should now be responsible for collecting, recording and analysing data on emerging trends in multiple drug use, including the combined use of legal and illegal psychotropic substances. In addition, the Centre will devise tools and methods for evaluating drug policies and strategies implemented in the European Union. The Centre will also be able to provide technical assistance to the western Balkans.
Secondly, in order to take account of enlargement, we have introduced a number of measures enabling the Centre to operate effectively in an enlarged Europe – for example the creation of a post of vice-chairman and a steering committee, and a review of the composition of the Centre's Scientific Committee. Given that the Scientific Committee is, by definition, a non-political body, we propose that it should be composed of only 18 experts appointed by the Centre's management board on the basis of their qualifications.
Thirdly, there is the question of the participation of the European Parliament in the management board. Given that Parliament is now the discharge authority for agencies, any potential conflict of interest that could arise should be avoided. I want to point out that out of the 15 Community agencies only three – the Environment Agency, the Medicines Agency and the Monitoring Centre on Racism and Xenophobia – have European Parliament representatives on their management boards.
The other new element in the Commission proposal is of a more technical nature, concerning either corrections related to the consolidation exercise or the updating of procedures in the new agencies.
To conclude, this proposal introduces simplifications through consolidation and it should enable the European Monitoring Centre for Drugs and Drug Addiction to operate effectively in an enlarged European Union."@en1
|
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples